Charles C. Collins, a pharmaceutical scientist and pharmacist, has been in pharmacy education and research since 1983. He is an active member and supporter of the premier pharmacy organizations, including APhA (1977-), AAPS (1986-), and AACP (1984-). He graduated from West Virginia University School of Pharmacy (BS 1977 and PhD 1984). He has been a faculty member at: Duquesne University in Pittsburgh, PA.; Palm Beach Atlantic University in West Palm Beach, FL and currently Professor of Pharmaceutical Sciences at East Tennessee State University Bill Gatton College of Pharmacy in Johnson City, TN. In addition to a significant basic science teaching load, he has maintained a research program and has authored many publications and several book chapters. He has made dissolution technology training presentations (on all aspects of dissolution testing) around the world, with particular expertise in the areas of drug release (method development and data interpretation) from transdermal and topical drug delivery systems. He supports professional school organizations and events as member and advisor for Kappa Psi, a member of Rho Chiand Phi Lambda Sigma, and participant in Relay for Life. During his 32 years in pharmacy education and research, his focus has been: (a) preparation of students to be the best pharmacists possible, (b) maintain professional and scientific excellence through independent and contract research, (c) be a positive contributor to school, university and the pharmacy scientific community, (d)exemplify that an educator can improve only when under a constant state of revision, and that (e) change must be with a reason or purpose in mind, never just to make a change. Dr. Collins has been a consultant for a variety of pharmaceutical companies, especially in the areas of drug release and drug dissolution testing.
High Performance Liquid Chromatography analysis of drug substances; Pharmacokinetic analysis of drug disposition; Development and in vitro testing of prolonged/sustained release dosage forms
a) For oral administration
b) Microencapsulation for injection
c) For buccal administration;Use and comparison of in vitro dissolution instruments
a) Standard and controlled release drug delivery systems
b) Topical and transdermal drug delivery systemsPolymer usage in controlled release dosage forms and as bioadhesives; Development and usage of in vitro drug release from transdermal and topical dosage forms as a method of quality control; In vitro and in vivo pharmacokinetic correlations; Pharmaceutical excipient evaluations (mainly direct compression)